Literature DB >> 17176501

Development of a new measure of health-related quality of life for people with dementia: DEMQOL.

S C Smith1, D L Lamping, S Banerjee, R H Harwood, B Foley, P Smith, J C Cook, J Murray, M Prince, E Levin, A Mann, M Knapp.   

Abstract

BACKGROUND: We identified the need to develop a scientifically rigorous measure of health-related quality of life (HRQL) in dementia that would be appropriate for use at all stages of dementia severity and would be available in both self- and proxy-report versions.
METHOD: We used standard psychometric methods to eliminate items with poor psychometric properties (item-reduction field test) and to assess the acceptability, reliability and validity of the item-reduced instruments (psychometric evaluation field test). We developed and validated two versions of DEMQOL: a 28-item interviewer-administered questionnaire that is self-reported by the person with dementia (DEMQOL) and a 31-item interviewer-administered questionnaire that is proxy-reported by a caregiver (DEMQOL-Proxy).
RESULTS: DEMQOL shows high reliability (internal consistency and test-retest) and moderate validity in people with mild/moderate dementia. DEMQOL-Proxy shows good acceptability and internal consistency and moderate evidence of validity in people with mild/moderate and severe dementia. Test-retest reliability and performance in people with severe dementia need further testing.
CONCLUSIONS: DEMQOL and DEMQOL-Proxy show psychometric properties that are comparable with the best available dementia-specific measures of HRQL. We recommend that DEMQOL and DEMQOL-Proxy are used together. Reliability and validity need to be confirmed in independent samples and responsiveness needs to be evaluated.

Entities:  

Mesh:

Year:  2006        PMID: 17176501     DOI: 10.1017/S0033291706009469

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  66 in total

1.  Measuring the experience and perception of suffering.

Authors:  Richard Schulz; Joan K Monin; Sara J Czaja; Jennifer H Lingler; Scott R Beach; Lynn M Martire; Angela Dodds; Randy S Hebert; Bozena Zdaniuk; Thomas B Cook
Journal:  Gerontologist       Date:  2010-05-17

2.  The Effects of Suffering in Chronically Ill Older Adults on the Health and Well-Being of Family Members Involved in Their Care: The Role of Emotion-Related Processes.

Authors:  Joan K Monin; Richard Schulz
Journal:  GeroPsych (Bern)       Date:  2010-12-01

3.  Magnitude and causes of bias among family caregivers rating Alzheimer disease patients.

Authors:  Richard Schulz; Thomas B Cook; Scott R Beach; Jennifer H Lingler; Lynn M Martire; Joan K Monin; Sara J Czaja
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-02       Impact factor: 4.105

4.  Dementia patient suffering and caregiver depression.

Authors:  Richard Schulz; Kathleen A McGinnis; Song Zhang; Lynn M Martire; Randy S Hebert; Scott R Beach; Bozena Zdaniuk; Sara J Czaja; Steven H Belle
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Apr-Jun       Impact factor: 2.703

5.  Quality of life impacts on 16-year survival of an older ethnically diverse cohort.

Authors:  Barry Gurland; Jeanne A Teresi; Joseph P Eimicke; Mathew S Maurer; M Carrington Reid
Journal:  Int J Geriatr Psychiatry       Date:  2013-10-29       Impact factor: 3.485

6.  Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort.

Authors:  Melanie T Gentry; Maria I Lapid; Jeremy Syrjanen; Kendrick Calvert; Samantha Hughes; Danielle Brushaber; Walter Kremers; Jessica Bove; Patrick Brannelly; Giovanni Coppola; Christina Dheel; Bradley Dickerson; Susan Dickinson; Kelley Faber; Julie Fields; Jamie Fong; Tatiana Foroud; Leah Forsberg; Ralitza Gavrilova; Deb Gearhart; Nupur Ghoshal; Jill Goldman; Jonathan Graff-Radford; Neill Graff-Radford; Murray Grossman; Dana Haley; Hilary Heuer; Ging-Yuek Hsiung; Edward Huey; David Irwin; David Jones; Lynne Jones; Kejal Kantarci; Anna Karydas; David Knopman; John Kornak; Joel Kramer; Walter Kukull; Diane Lucente; Codrin Lungu; Ian Mackenzie; Masood Manoochehri; Scott McGinnis; Bruce Miller; Rodney Pearlman; Len Petrucelli; Madeline Potter; Rosa Rademakers; Eliana Marisa Ramos; Katherine Rankin; Katya Rascovsky; Pheth Sengdy; Leslie Shaw; Nadine Tatton; Joanne Taylor; Arthur Toga; John Trojanowski; Sandra Weintraub; Bonnie Wong; Zbigniew Wszolek; Bradley F Boeve; Adam Boxer; Howard Rosen
Journal:  Alzheimers Dement       Date:  2020-07-13       Impact factor: 21.566

7.  Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease.

Authors:  Douglas Galasko; Joanne Bell; Jessica Y Mancuso; James W Kupiec; Marwan N Sabbagh; Christopher van Dyck; Ronald G Thomas; Paul S Aisen
Journal:  Neurology       Date:  2014-04-02       Impact factor: 9.910

8.  Dementia Care Mapping™ to reduce agitation in care home residents with dementia: the EPIC cluster RCT.

Authors:  Claire A Surr; Ivana Holloway; Rebecca Ea Walwyn; Alys W Griffiths; David Meads; Rachael Kelley; Adam Martin; Vicki McLellan; Clive Ballard; Jane Fossey; Natasha Burnley; Lynn Chenoweth; Byron Creese; Murna Downs; Lucy Garrod; Elizabeth H Graham; Amanda Lilley-Kelley; Joanne McDermid; Holly Millard; Devon Perfect; Louise Robinson; Olivia Robinson; Emily Shoesmith; Najma Siddiqi; Graham Stokes; Daphne Wallace; Amanda J Farrin
Journal:  Health Technol Assess       Date:  2020-03       Impact factor: 4.014

9.  Assessment scales in dementia.

Authors:  Bart Sheehan
Journal:  Ther Adv Neurol Disord       Date:  2012-11       Impact factor: 6.570

10.  Tibial nerve stimulation compared with sham to reduce incontinence in care home residents: ELECTRIC RCT.

Authors:  Joanne Booth; Lorna Aucott; Seonaidh Cotton; Bridget Davis; Linda Fenocchi; Claire Goodman; Suzanne Hagen; Danielle Harari; Maggie Lawrence; Andrew Lowndes; Lisa Macaulay; Graeme MacLennan; Helen Mason; Doreen McClurg; John Norrie; Christine Norton; Catriona O'Dolan; Dawn Skelton; Claire Surr; Shaun Treweek
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.